Usefulness of galactose oxidase-Schiff test in rectal mucus for screening of colorectal malignancy

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1247-1256

  Vucenik, I ^a   Gotovac, J ^a   Druzijanic, N ^a   Shamsuddin, A M ^a  

^a NONE   (United States)

Author keywords

Colorectal cancer; Field effect; GO test; Tumor marker

Indexed keywords

CARCINOGEN; DISACCHARIDE; GALACTOSE; GALACTOSE OXIDASE; MUCIN; N ACETYLGALACTOSAMINE;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURGERY; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; GALACTOSE OXIDASE SCHIFF TEST; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEMBRANE FILTER; MUCUS; POSTOPERATIVE PERIOD; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECTUM MUCOSA; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

COLONIC POLYPS; COLORECTAL NEOPLASMS; GALACTOSE OXIDASE; HUMANS; INDICATORS AND REAGENTS; MUCUS; POPULATION SURVEILLANCE; RECTUM; SULFHYDRYL COMPOUNDS;

EID: 0035016153     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Carbohydrate antigens on cancer-associated mucin like molecules
2. Mucins: Structure, functions, and association with malignancy
3. Mucin glycoproteins in neoplasia
4. Perspectives on the significance of altered glycosylation of glycoproteins in cancer
5. The purification, composition and specificity of anti-T lectin from peanut (Arachis hypogaea)
6. Peanut lectin-binding sites in large bowel carcinoma
7. Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation
8. Expression of carcinoembryonic antigen, T-antigen and oncogene products as markers of neoplastic and preneoplastic colonic mucosa
9. Detection of the tumor marker D-galactose-(-[1→3]-N-acetyl-D-galactosamine in colonic cancer and precancer
10. Gal-GalNAc: A biomarker of colon carcinogenesis
11. Colon epithelium. IV. Human colon carcinogenesis. Changes in human colon mucosa adjacent to and remote from carcinomas of the colon
12. Common expression of the tumor marker D-galactose-(-[1(3]-N-acetyl-D-galactosamine by different adenocarcinomas: Evidence of field effect phenomenon
13. "Field cancerization" in oral stratified squamous epithelium
14. Detection of altered glyco-conjugate in preneoplastic and neoplastic human large intestinal epithelia by galactose oxidase-Schiff sequence
15. Comparison of different techniques for detection of Gal-GalNAc, an early marker of colonic neoplasia
16. A test for detection of colorectal cancer
17. A simple mucus test for cancer screening
18. A pilot study on the usefulness of a new test for mass screening of colorectal cancer in Japan
19. Evaluation of a new test for colorectal neoplasms: A prospective study of asymptomatic population
20. Screening of colorectal cancer by testing rectal mucus for (-D-Gal(1→3)-D-GalNAc (T-antigen)
21. The galactose oxidase test for detection of colorectal cancer
22. Screening of colorectal cancer by testing rectal mucus for T antigen
23. The colon mucus test in comparison with the fecal occult blood test in the detection of gastrointestinal disease
24. An evaluation of a new mass survey for colorectal cancer using galactose oxidase test
25. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening: Analysis of a check-up of 6480 asymptomatic subjects
26. Comparison of a T-antigen test for rectal mucus to an immunological fecal occult blood test in screening of large intestinal carcinoma
27. Detection of large bowel cancer using galactose oxidase test
28. Screening for colonic adenoma using Shams test
29. Clinical screening for colonic cancer using GO-S kit
30. The value of tumor marker T-antigen in the diagnosis of colon cancer and precancer in clinical screening
31. Clinical screening of colorectal cancer by testing galactose oxidase
32. Screening of colonic polyps using galactose oxidase
33. Screening of colorectal cancer using galactose oxidase
34. Analytical goals and clinical relevance of laboratory procedures
35. Cancer statistics, 2000
36. Colorectal cancer: Risk factors and recommendations for early detection
37. Screening guidelines for colorectal cancer
38. Colorectal cancer screening: A guide to the guidelines
39. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists
40. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening
41. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
42. Patient preferences for colon cancer screening
43. Limitations of the faecal occult blood test in screening for colorectal cancer
44. Does isolated rectal bleeding suggest colorectal cancer?
45. Flat adenomas exist in asymptomatic people: Important implications for colorectal cancer screening programs
46. Abstracts, Comment and Response
47. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests
48. A genetic model for colorectal tumorigenesis
49. Colon epithelium. II. In vivo studies of colon carcinogenesis. Light microscopic, histochemical, and ultrastructural studies of the histogenesis of azoxymethane-induced colon carcinomas in Fisher 344 rats
50. Validation of the galactose oxidase-Schiff's reagent sequence for early detection and prognosis in human colorectal adenocarcinoma
51. Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: Early results of a prospective study
52. T-antigen expression by peanut agglutinin staining relates to mucosal dysplasia in ulcerative colitis
53. Glycoconjugates in the colons of new world monkeys with spontaneous colitis
54. Detection of colorectal neoplasia with peanut-agglutinin (PNA)-reactive carbohydrate structures in rectal mucus
55. Prevention of cancer in the next millennium: Report of the chemoprevention working group to the American Association for Cancer Research
56. Lectin reactivities as intermediate biomarkers in premalignant colorectal epithelium
57. Intermediate biomarkers of increased risk for colorectal cancer: Comparison of different methods of analysis and modifications by chemopreventive interventions
58. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid)